Christopher Wolfe, OD

speaker

205 appearances 1 recordings 1 series first heard May 2026 last heard 18 May

Christopher Wolfe, OD’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in May 2026 with 1.

Appearances

newest first · ▶ plays the moment

EyeCode Media · The Chris Wolfe Podcast: All Things Caratenoids w/ Kirsten Ormsby · 18 May 2026 podcast

Unfortunately, dry eye and inflammation are part of everyday practice, and omega-3s are the foundation of helping patients with those two conditions that really play into one another.

TG3 omegas are the formulation we use for our patients because it's a triglyceride-bound formulation, which means better absorption and fewer GI complaints.

Patients who couldn't tolerate other omega-3s do great with TG3.

For dry eye, MGD, and overall ocular surface support, it's our go-to.

Check out TG3 omegas.

So I think you might be the first person I've talked to that has made that distinction of sort of –

um, thinking about them as different isomers.

And then that does sort of explain why some may be more important than others, but we're, we may not be looking at them differently.

And actually that's kind of like a, a very, um, uh, it's a very charitable way to look at, you know, I, I kind of, sometimes I look at, uh, at studies and I'm a little less charitable, but that's a very charitable way to look at like why studies didn't, didn't show the same thing.

Um,

Okay, so can you continue to unpack that?

I think I've interrupted you enough, but I feel like I have an understanding now.

You're blowing our minds.

Yeah.

Passing the microphone over.

It can't convert it.

Oh, we can tell.

Half of them have the enzyme and half of them do not.

Does that, does that wait?

So back that up a little bit.

Showing 61–80 of 205 · page 4 of 11